Francou Bruno, Paul Charlotte, Amazit Larbi, Cartes Alejandra, Bouvattier Claire, Albarel Frédérique, Maiter Dominique, Chanson Philippe, Trabado Séverine, Brailly-Tabard Sylvie, Brue Thierry, Guiochon-Mantel Anne, Young Jacques, Bouligand Jérôme
Univ Paris-Sud, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Le Kremlin Bicêtre, France INSERM Unité Mixte de Recherche 1185, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Le Kremlin Bicêtre F-94276, France Service de Génétique Moléculaire, Pharmacogénétique, et Hormonologie, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Le Kremlin Bicêtre, France.
INSERM Unité Mixte de Recherche 1185, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Le Kremlin Bicêtre F-94276, France.
Hum Reprod. 2016 Jun;31(6):1363-74. doi: 10.1093/humrep/dew073. Epub 2016 Apr 19.
What is the exact prevalence of Kisspeptin Receptor (KISS1R) mutations in the population of patients with normosmic congenital hypogonadotrophic hypogonadism (nCHH) by comparison with other genes, involved in gonadotrophin-releasing hormone (GnRH) release or action?
KISS1R mutants are responsible for the nCHH phenotype in only a small minority of cases and were less prevalent than GnRH Receptor (GNRHR) mutations.
The respective prevalence of each of the genetic causes of nCHH is unclear. Large series of patients are very rare and suffer from heterogeneity of the population of CHH studied.
STUDY DESIGN, SIZE, DURATION: Patients with nCHH were consecutively enrolled in a single French referral centre and were gradually tested for KISS1R between January 2006 and April 2015.
PARTICIPANTS/MATERIALS, SETTING, METHODS: A total of 603 patients with nCHH (399 men and 204 women) were diagnosed at the Bicêtre Hospital and underwent KISS1R analysis. The GNRHR, tachykinin receptor 3 (TACR3), gonadotrophin-releasing hormone 1 (GNRH1), tachykinin 3 (TAC3) and KISS1 genes were also sequenced. Functional characterization of KISS1R mutations included a study of signal transduction using a reporter gene (serum response element-luciferase (SRE-Luc) involved in the mitogen-activated protein (MAP) kinase pathway.
We detected 15 KISS1R variants (10 novel), in 12 of the 603 patients (2.0%, 95% CI [0.9-3.1]. KISS1R mutations were less prevalent than GNRHR (4.7%) and TACR3 (2.6%) mutations but more prevalent than GNRH1 (1.5%), TAC3 (1.0%) and KISS1 (0%) mutations. KISS1R mutants were present in the biallelic state in 8 of the 12 patients concerned. Among 5 men with biallelic KISS1R mutations, 4 had either micropenis or cryptorchidism. In vitro analysis of the 5 new variants present in the biallelic state (C95W, Y103*, C115W, P176R and A287E) showed a loss of function.
LIMITATIONS, REASONS FOR CAUTION: The prevalence of TACR3, GNRH1, TAC3 and KISS1 mutations was calculated from a smaller number of nCHH patients than KISS1R and GNRHR. This should prompt caution concerning the reported prevalence of mutations in these four genes.
We show that KISS1R mutants are responsible for the nCHH phenotype in only a small minority of cases. Together, the genes analysed here were mutated in fewer than 15% of patients, suggesting a role of other genes in nCHH. The presence of cryptorchidism and/or micropenis in the majority of men with biallelic KISS1R mutations strongly suggests that this gene is essential for prenatal GnRH secretion.
STUDY FUNDING, COMPETING INTERESTS: This work was supported in part by grants from Paris-Sud University (Bonus Qualité Recherche, and Attractivité grants) to J.B., French Ministry of Health, Hospital Clinical Research Program on Rare Diseases. Assistance Publique Hôpitaux de Paris, Programme Hospitalier de Recherche Clinique (PHRC # P081212 HYPOPROTEO) to J.Y. C.P. was supported by student fellowships 'Année Recherche' from Agence Régionale de Santé Provence Alpes Côtes d'Azur. The authors have nothing to disclose.
与参与促性腺激素释放激素(GnRH)释放或作用的其他基因相比,嗅觉正常的先天性低促性腺激素性性腺功能减退症(nCHH)患者群体中亲吻素受体(KISS1R)突变的确切患病率是多少?
KISS1R突变仅在少数病例中导致nCHH表型,且其患病率低于GnRH受体(GNRHR)突变。
nCHH各遗传病因的具体患病率尚不清楚。大量患者系列非常罕见,且所研究的CHH患者群体存在异质性。
研究设计、规模、持续时间:nCHH患者在法国一家转诊中心连续入组,并于2006年1月至2015年4月期间逐步接受KISS1R检测。
参与者/材料、环境、方法:共有603例nCHH患者(399例男性和204例女性)在比塞特尔医院被诊断,并接受了KISS1R分析。同时对GNRHR、速激肽受体3(TACR3)、促性腺激素释放激素1(GNRH1)、速激肽3(TAC3)和KISS1基因进行了测序。KISS1R突变的功能特性包括使用报告基因(参与丝裂原活化蛋白(MAP)激酶途径的血清反应元件 - 荧光素酶(SRE - Luc))对信号转导进行研究。
我们在603例患者中的12例(2.0%,95%置信区间[0.9 - 3.1])中检测到15种KISS1R变异(10种为新变异)。KISS1R突变的患病率低于GNRHR(4.7%)和TACR3(2.6%)突变,但高于GNRH1(1.5%)、TAC3(1.0%)和KISS1(0%)突变。在12例相关患者中,8例的KISS1R突变呈双等位基因状态。在5例双等位基因KISS1R突变的男性中,4例有小阴茎或隐睾症。对呈双等位基因状态的5种新变异(C95W、Y103*、C115W、P176R和A287E)的体外分析显示功能丧失。
局限性、注意事项:TACR3、GNRH1、TAC3和KISS1突变的患病率是根据比KISS1R和GNRHR数量更少的nCHH患者计算得出的。这应提醒人们对这四个基因中报道的突变患病率保持谨慎。
我们表明KISS1R突变仅在少数病例中导致nCHH表型。总体而言,此处分析的基因在不到15%的患者中发生突变,提示其他基因在nCHH中发挥作用。大多数双等位基因KISS1R突变男性中存在隐睾症和/或小阴茎,强烈表明该基因对产前GnRH分泌至关重要。
研究资金、利益冲突:这项工作部分得到了巴黎 - 南大学(优秀研究奖金和吸引力资助)授予J.B.的资助、法国卫生部、罕见病医院临床研究项目。巴黎公立医院集团、医院临床研究项目(PHRC # P081212 HYPOPROTEO)授予J.Y.的资助。C.P.得到了普罗旺斯 - 阿尔卑斯 - 蓝色海岸地区卫生局“研究年度”学生奖学金的支持。作者无利益冲突需披露。